Price $3.03 |
Market Cap
390M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
3.38
|
Dividend %
-
|
|
P/CF
5.5
|
P/FCF
-
|
Op. Cash Flow
-19.4K
|
FCF
-0.2
|
|
Op. Margin
-70.00%
|
Net Margin
-98.60%
|
ROE
78.60%
|
ROI
84.50%
|
|
ROA
-62.90%
|
EPS Growth
37.80%
|
Current Ratio
1.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| iCAD Inc (ICAD) | $7.45 | - | - | 110.6M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $22.86 | - | - | 7.58B | Strong Buy |
| Endo International PLC (ENDP) | $3.48 | - | - | 556.9M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.38 | - | - | 76.9M | Strong Buy |
| Hologic, Inc. (HOLX) | $49.95 | - | - | 13.14B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
